A chemoenzymatic synthesis method of a blood group trisaccharide
Through chemical enzymatic synthesis method, the reaction of enzyme α1,2-FucT and glycosyltransferase was adopted, combined with the enzyme removal solvent treatment and purification steps, and the blood type trisaccharide A and B were successfully prepared, solving the scarcity and expensive problems of blood type trisaccharide synthesis in the prior art, and providing key raw materials to support multi-field applications.
Patent Information
- Application Number
- CN202510369392.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-27
- Publication Date
- 2025-07-25
- Estimated Expiration
- 2045-03-27
AI Technical Summary
The chemical enzymatic synthesis method of blood type trisaccharide A and B in the prior art has not been reported, resulting in scarce market supply and expensive, which cannot meet research and application needs.
The chemical enzyme synthesis method is adopted, including steps S1 to S6, and blood type trisaccharides A and B are prepared by the reaction of enzyme α1,2-FucT and glycosyltransferase, combined with the enzyme removal solvent treatment and purification steps.
The efficient and direct preparation of blood type trisaccharides A and B is achieved, solving the problem of low yield and expensive prices, and providing key raw materials for sugar-protein/antibody research, coupling drug development, in vitro diagnosis and medical device consumables.